PATENT CLAIM ANALYSIS

Application Number: 16149913
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-04
Patent Classification: ["560", "124000"]

Abstract:
A method of inhibiting the conversion of choline to trimethylamine (TMA) and lowering TMAO in an individual by providing a composition comprising a compound set forth in Formula (I):

Claim (Index 8):
The method of  claim 4 , comprising administering the compound to an individual having an elevated level of TMAO in blood, plasma, serum, or urine, and combinations thereof.

Metadata:
- Claim Count in Document: 15.0
- Percentile: 97.0
- Lexical Diversity: 1.17241
- Patent Class: 560.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15366940', '14866398', '15605437', '13915299', '13363661']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7085037672614836
- 35 USC 102 Novelty (BERT): 0.5634920014856054
- Combined Prediction Score: 0.6940025906838958
- Mean Citation Score: 245.85887
- Max Citation Score: 376.33347
- Similarity Product: 203.8076677563929

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test